区域贫困指数的协会在癌死亡率中的区域贫困指数
Silvia Viganò1,2, Anna Tylecki3, Alessandro Bertini1,4
1VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan.
Urology practice
|December 15, 2025
概括
通过区域贫困指数 (ADI) 衡量社会经济地位,显著影响癌存活率. 贫困地区的患者面临更高的癌症特异性和整体死亡风险.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 健康差异 在健康上的差异
背景情况:
- 社会经济地位是已知的健康结果的决定因素.
- 癌存活率的差异与社会经济因素有关.
- 区域贫困指数 (ADI) 量化了社区层面的社会经济劣势.
研究的目的:
- 调查区域贫困指数 (ADI) 与癌患者死亡率之间的关联.
- 为了比较不同水平的地区贫困的癌症特异性死亡率 (CSM) 和总死亡率 (OM).
- 分析这些协会在北美州范围内的队列.
主要方法:
- 利用密歇根州卫生与人类服务部的数据库,对2004-2019年间诊断的细胞癌患者进行了分析.
- 根据居住人口普查区组分配的ADI,分为国家四分之一 (1=最贫困,4=最贫困).
- 用于CSM的竞争风险回归和OM的Cox回归,比较ADI四分位数.
主要成果:
- 包括9210名患者;35.6%来自最贫困的四分之一 (ADI 75-100).
- 与最贫困的四分之一相比,ADI最高的四分之一患者的10年癌症特异性死亡率 (26.4%vs25.6%) 和整体死亡率 (72.8%vs60.7%) 显着更高.
- 多变量分析显示,CSM (1.38-1.62) 和OM (1.41-1.58) 的危险比率增加,与最低的ADI四分位数相比,ADI四分位数更高.
结论:
- 区域贫困指数 (ADI) 与不良癌结果有显著的相关性.
- 居住在更贫困地区的患者表现出更高的癌症特异性和整体死亡率风险.
- 研究结果强调了社会经济因素对癌存活率的影响.
相关概念视频
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
171
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
171
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
243
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
243
01:22Acute Kidney Injury I: Introduction
519
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
519
01:24Chronic Kidney Disease II: Clinical Manifestations
522
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
522
01:25Chronic Kidney Disease I: Introduction
541
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
541
01:29Acute Kidney Injury III: Clinical Manifestations
769
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
769